cyc 202 has been researched along with myelin basic protein in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (myelin basic protein) | Trials (myelin basic protein) | Recent Studies (post-2010) (myelin basic protein) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 7,478 | 78 | 1,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casaccia-Bonnefil, P; Marin-Husstege, M; Miskimins, R; Miskimins, WK; Srinivasan, R | 1 |
1 other study(ies) available for cyc 202 and myelin basic protein
| Article | Year |
|---|---|
p27(Kip1) enhances myelin basic protein gene promoter activity.
Topics: 3T3 Cells; Animals; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Central Nervous System; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinase Inhibitor p57; Cyclin-Dependent Kinases; Enzyme Inhibitors; Gene Expression Regulation; Genes, Reporter; Luciferases; Mice; Myelin Basic Protein; Nuclear Proteins; Oligodendroglia; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Purines; Roscovitine; Stem Cells; Transcription, Genetic; Transfection; Tumor Suppressor Proteins | 2002 |